Amarin Corp Plc (AMRN)

[KCSVEN]

Yes and no since the study is small it would need a larger follow up study to confirm the results and benefits. So then it would come down to how great are the results, will it be so great there is a lot of off label use?
I would imagine good results would have the medical community with a need to confirm results in a larger study as per the study design:

"The overarching goal of this trial is to assess whether icosapent ethyl beneficially affects intermediate physiological measures associated with onset of AD in order to evaluate whether larger, multi-site, longer-duration Alzheimer's prevention trials are warranted to assess more definitive clinical outcomes."

So really iffy if this study would lead to floodgates being open unless results were ridiculous overwhelming (unlikely in any trial but always possible), it is more likely that it would take several more years after to confirm positive results in a larger study.